Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
941 to 960 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Verification of SARS-CoV-2-encoded small RNAs and contribution to infection-associated lung inflammation. | Chin Med J (Engl) | 2022 | 35838380 | PubTator, text mining | PubMed |
| Recombinant human C1 esterase inhibitor as prophylactic treatment in idiopathic non-histaminergic angioedema. | Allergy | 2022 | 35837765 | PubTator, text mining | PubMed |
| Clinicopathological Characteristics and Molecular Phenotypes of Primary Hepatic Lymphoma. | Front Oncol | 2022 | 35832546 | PubTator, text mining | PubMed |
| Considerations in the management of hereditary angioedema due to C1-INH deficiency in women of childbearing age. | Allergy Asthma Clin Immunol | 2022 | 35831891 | PubTator, text mining | PubMed |
| Mutation update of SERPING1 related to hereditary angioedema in the Chinese population. | Hereditas | 2022 | 35821062 | PubTator, text mining | PubMed |
| Characteristics of Patients Who Underwent a Diagnostic Test for Hereditary Angioedema Admitted Due to Angioedema. | J Trop Pediatr | 2022 | 35818890 | PubTator, text mining | PubMed |
| Screening of Gene Expression Markers for Corona Virus Disease 2019 Through Boruta_MCFS Feature Selection. | Front Public Health | 2022 | 35812497 | PubTator, text mining | PubMed |
| Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity. | Front Immunol | 2022 | 35812405 | PubTator, text mining | PubMed |
| Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals. | Front Immunol | 2022 | 35812392 | PubTator, text mining | PubMed |
| The trichloroethylene metabolite S-(1,2-dichlorovinyl)-l-cysteine inhibits lipopolysaccharide-induced inflammation transcriptomic pathways and cytokine secretion in a macrophage cell model. | Toxicol In Vitro | 2022 | 35811015 | PubTator, text mining | PubMed |
| Investigation of the Molecular Mechanisms Underlying the Antiatherogenic Actions of Kaempferol in Human THP-1 Macrophages. | Int J Mol Sci | 2022 | 35806463 | PubTator, text mining | PubMed |
| Peptidomic Approaches and Observations in Neurodegenerative Diseases. | Int J Mol Sci | 2022 | 35806335 | PubTator, text mining | PubMed |
| The Transcriptional Landscape of BRAF Wild Type Metastatic Melanoma: A Pilot Study. | Int J Mol Sci | 2022 | 35805902 | PubTator, text mining | PubMed |
| Effects of Omega-3 and Antioxidant Cocktail Supplement on Prolonged Bed Rest: Results from Serum Proteome and Sphingolipids Analysis. | Cells | 2022 | 35805205 | PubTator, text mining | PubMed |
| Theranostic Potentials of Gold Nanomaterials in Hematological Malignancies. | Cancers (Basel) | 2022 | 35804818 | PubTator, text mining | PubMed |
| Factitious Disorder: An Angioedema Copycat. | Cureus | 2022 | 35795523 | PubTator, text mining | PubMed |
| In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependencies. | Blood Adv | 2022 | 35793392 | PubTator, text mining | PubMed |
| Systematic review of host genomic biomarkers of invasive bacterial disease: Distinguishing bacterial from non-bacterial causes of acute febrile illness. | EBioMedicine | 2022 | 35792524 | PubTator, text mining | PubMed |
| A novel pathogenetic factor of laryngeal attack in hereditary angioedema? Involvement of protease activated receptor 1. | Allergy Asthma Clin Immunol | 2022 | 35787812 | PubTator, text mining | PubMed |
| As in Real Estate, Location Matters: Cellular Expression of Complement Varies Between Macular and Peripheral Regions of the Retina and Supporting Tissues. | Front Immunol | 2022 | 35784369 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=48